Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (621-630 of 811) with videos related to

Pageof 82
Sort By:
Journal of the National Cancer Institute|October 19, 2025
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysisYago Garitaonaindia, Shawez Khan, Rasmus Friis, et al.
Plos One|September 10, 2009
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenaseRikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, et al.
European Journal of Haematology|July 13, 2019
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatmentAnders Lindholm Sørensen, Mads Emil Bjørn, Caroline H Riley, et al.
ACS Materials Au|September 16, 2024
Impact of Nickel on Iridium-Ruthenium Structure and Activity for the Oxygen Evolution Reaction under Acidic ConditionsErlend Bertheussen, Simon Pitscheider, Susan R Cooper, et al.
Cancer Immunology, Immunotherapy : CII|July 4, 2021
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trialStaffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 18, 2020
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgeryChristoffer Martinussen, Simon Veedfald, Carsten Dirksen, et al.
Genes|February 9, 2018
DNA Methylation and All-Cause Mortality in Middle-Aged and Elderly Danish TwinsAnne Marie Svane, Mette Soerensen, Jesper Lund, et al.
International Journal of Cancer|April 24, 2026
Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian CancerTine J Monberg, Cathrine L Lorentzen, Marie C W Westergaard, et al.
Frontiers in Immunology|June 26, 2023
<i>Ex vivo</i> modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytesThomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, et al.
Acta Oncologica (Stockholm, Sweden)|January 16, 2023
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapySidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, et al.
Pageof 82

Showing results (621-630 of 811) with videos related to

Sort By:
Pageof 82
Journal of the National Cancer Institute|October 19, 2025
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysisYago Garitaonaindia, Shawez Khan, Rasmus Friis, et al.
Plos One|September 10, 2009
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenaseRikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, et al.
European Journal of Haematology|July 13, 2019
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatmentAnders Lindholm Sørensen, Mads Emil Bjørn, Caroline H Riley, et al.
ACS Materials Au|September 16, 2024
Impact of Nickel on Iridium-Ruthenium Structure and Activity for the Oxygen Evolution Reaction under Acidic ConditionsErlend Bertheussen, Simon Pitscheider, Susan R Cooper, et al.
Cancer Immunology, Immunotherapy : CII|July 4, 2021
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trialStaffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 18, 2020
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgeryChristoffer Martinussen, Simon Veedfald, Carsten Dirksen, et al.
Genes|February 9, 2018
DNA Methylation and All-Cause Mortality in Middle-Aged and Elderly Danish TwinsAnne Marie Svane, Mette Soerensen, Jesper Lund, et al.
International Journal of Cancer|April 24, 2026
Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian CancerTine J Monberg, Cathrine L Lorentzen, Marie C W Westergaard, et al.
Frontiers in Immunology|June 26, 2023
<i>Ex vivo</i> modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytesThomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, et al.
Acta Oncologica (Stockholm, Sweden)|January 16, 2023
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapySidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, et al.
Pageof 82